vs
CAPRICOR THERAPEUTICS, INC.（CAPR）与Digimarc CORP（DMRC）财务数据对比。点击上方公司名可切换其他公司
CAPRICOR THERAPEUTICS, INC.的季度营收约是Digimarc CORP的1.2倍（$11.1M vs $8.9M），Digimarc CORP净利率更高（-47.2% vs -63.9%，领先16.7%），Digimarc CORP同比增速更快（2.9% vs -7.9%），Digimarc CORP自由现金流更多（$895.0K vs $-15.3M），过去两年CAPRICOR THERAPEUTICS, INC.的营收复合增速更高（93.0% vs -5.3%）
Capricor Therapeutics是一家处于临床阶段的生物技术企业，专注于研发及商业化细胞疗法、基因疗法等创新生物制剂，覆盖罕见病、心血管疾病、肌肉疾病等领域，主要面向美国市场，致力为治疗选择有限的患者填补未被满足的医疗需求。
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
CAPR vs DMRC — 直观对比
营收规模更大
CAPR
是对方的1.2倍
$8.9M
营收增速更快
DMRC
高出10.8%
-7.9%
净利率更高
DMRC
高出16.7%
-63.9%
自由现金流更多
DMRC
多$16.2M
$-15.3M
两年增速更快
CAPR
近两年复合增速
-5.3%
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.1M | $8.9M |
| 净利润 | $-7.1M | $-4.2M |
| 毛利率 | — | 63.5% |
| 营业利润率 | -69.1% | -48.2% |
| 净利率 | -63.9% | -47.2% |
| 营收同比 | -7.9% | 2.9% |
| 净利润同比 | -833.8% | 51.4% |
| 每股收益（稀释后） | $-0.11 | $-0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CAPRDMRC
| Q4 25 | — | $8.9M | ||
| Q3 25 | — | $7.6M | ||
| Q2 25 | — | $8.0M | ||
| Q1 25 | — | $9.4M | ||
| Q4 24 | $11.1M | $8.7M | ||
| Q3 24 | $2.3M | $9.4M | ||
| Q2 24 | $4.0M | $10.4M | ||
| Q1 24 | $4.9M | $9.9M |
净利润CAPRDMRC
| Q4 25 | — | $-4.2M | ||
| Q3 25 | — | $-8.2M | ||
| Q2 25 | — | $-8.2M | ||
| Q1 25 | — | $-11.7M | ||
| Q4 24 | $-7.1M | $-8.6M | ||
| Q3 24 | $-12.6M | $-10.8M | ||
| Q2 24 | $-11.0M | $-9.3M | ||
| Q1 24 | $-9.8M | $-10.3M |
毛利率CAPRDMRC
| Q4 25 | — | 63.5% | ||
| Q3 25 | — | 58.3% | ||
| Q2 25 | — | 58.8% | ||
| Q1 25 | — | 65.0% | ||
| Q4 24 | — | 60.8% | ||
| Q3 24 | — | 62.4% | ||
| Q2 24 | — | 66.1% | ||
| Q1 24 | — | 62.5% |
营业利润率CAPRDMRC
| Q4 25 | — | -48.2% | ||
| Q3 25 | — | -109.7% | ||
| Q2 25 | — | -105.2% | ||
| Q1 25 | — | -128.9% | ||
| Q4 24 | -69.1% | -105.1% | ||
| Q3 24 | -575.2% | -120.4% | ||
| Q2 24 | -291.9% | -96.2% | ||
| Q1 24 | -209.2% | -109.2% |
净利率CAPRDMRC
| Q4 25 | — | -47.2% | ||
| Q3 25 | — | -106.9% | ||
| Q2 25 | — | -102.6% | ||
| Q1 25 | — | -125.2% | ||
| Q4 24 | -63.9% | -99.9% | ||
| Q3 24 | -555.2% | -113.9% | ||
| Q2 24 | -277.0% | -89.3% | ||
| Q1 24 | -199.6% | -104.0% |
每股收益（稀释后）CAPRDMRC
| Q4 25 | — | $-0.18 | ||
| Q3 25 | — | $-0.38 | ||
| Q2 25 | — | $-0.38 | ||
| Q1 25 | — | $-0.55 | ||
| Q4 24 | $-0.11 | $-0.40 | ||
| Q3 24 | $-0.38 | $-0.50 | ||
| Q2 24 | $-0.35 | $-0.43 | ||
| Q1 24 | $-0.31 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $151.5M | $12.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $145.5M | $40.2M |
| 总资产 | $170.5M | $53.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CAPRDMRC
| Q4 25 | — | $12.9M | ||
| Q3 25 | — | $12.6M | ||
| Q2 25 | — | $16.1M | ||
| Q1 25 | — | $21.6M | ||
| Q4 24 | $151.5M | $28.7M | ||
| Q3 24 | $85.0M | $33.7M | ||
| Q2 24 | $29.5M | $41.5M | ||
| Q1 24 | $39.9M | $48.9M |
股东权益CAPRDMRC
| Q4 25 | — | $40.2M | ||
| Q3 25 | — | $41.4M | ||
| Q2 25 | — | $46.5M | ||
| Q1 25 | — | $50.0M | ||
| Q4 24 | $145.5M | $61.4M | ||
| Q3 24 | $68.3M | $70.2M | ||
| Q2 24 | $11.5M | $77.2M | ||
| Q1 24 | $18.4M | $84.5M |
总资产CAPRDMRC
| Q4 25 | — | $53.0M | ||
| Q3 25 | — | $55.4M | ||
| Q2 25 | — | $60.7M | ||
| Q1 25 | — | $66.5M | ||
| Q4 24 | $170.5M | $75.8M | ||
| Q3 24 | $93.0M | $85.0M | ||
| Q2 24 | $38.3M | $93.4M | ||
| Q1 24 | $49.4M | $99.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.8M | $991.0K |
| 自由现金流经营现金流 - 资本支出 | $-15.3M | $895.0K |
| 自由现金流率自由现金流/营收 | -137.3% | 10.0% |
| 资本支出强度资本支出/营收 | 4.4% | 1.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-41.2M | $-12.3M |
8季度趋势，按日历期对齐
经营现金流CAPRDMRC
| Q4 25 | — | $991.0K | ||
| Q3 25 | — | $-2.6M | ||
| Q2 25 | — | $-4.7M | ||
| Q1 25 | — | $-5.5M | ||
| Q4 24 | $-14.8M | $-4.2M | ||
| Q3 24 | $-11.6M | $-7.1M | ||
| Q2 24 | $-12.3M | $-6.8M | ||
| Q1 24 | $-1.3M | $-8.4M |
自由现金流CAPRDMRC
| Q4 25 | — | $895.0K | ||
| Q3 25 | — | $-2.8M | ||
| Q2 25 | — | $-4.9M | ||
| Q1 25 | — | $-5.5M | ||
| Q4 24 | $-15.3M | $-4.2M | ||
| Q3 24 | $-11.7M | $-7.2M | ||
| Q2 24 | $-12.3M | $-6.9M | ||
| Q1 24 | $-1.9M | $-8.5M |
自由现金流率CAPRDMRC
| Q4 25 | — | 10.0% | ||
| Q3 25 | — | -36.9% | ||
| Q2 25 | — | -61.0% | ||
| Q1 25 | — | -59.1% | ||
| Q4 24 | -137.3% | -49.1% | ||
| Q3 24 | -515.2% | -75.7% | ||
| Q2 24 | -310.9% | -66.1% | ||
| Q1 24 | -38.3% | -85.8% |
资本支出强度CAPRDMRC
| Q4 25 | — | 1.1% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 2.5% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | 4.4% | 0.2% | ||
| Q3 24 | 0.4% | 0.7% | ||
| Q2 24 | 1.5% | 0.3% | ||
| Q1 24 | 12.4% | 1.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CAPR
暂无分部数据
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
